Lexington biotech startup homes in on a new kind of precision cancer drug
When Robert Copeland explains the science behind his new cancer drug startup, Accent Therapeutics, he uses the analogy of building a house: an architect makes a blueprint, and a builder translates it into a physical structure. That ’s also how cellular biology works, he says: DNA is transcribed into RNA, which produces proteins.
But as in the case of building a house, it’s a little more complicated than that. Just as a homeowner will make modifications to put their personal stamp on a property…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Max Stendahl Source Type: news
More News: Biology | Biotechnology | Cancer | Cancer & Oncology | Health Management | Pharmaceuticals | Science